The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease

TY - JOUR

T1 - The sickle cell disease implementation consortium

T2 - Translating evidence-based guidelines into practice for sickle cell disease

AU - for the Sickle Cell Disease Implementation Consortium

AU - DiMartino, Lisa D.

AU - Baumann, Ana A.

AU - Hsu, Lewis L.

AU - Kanter, Julie

AU - Gordeuk, Victor R.

AU - Glassberg, Jeffrey

AU - Treadwell, Marsha J.

AU - Melvin, Cathy L.

AU - Telfair, Joseph

AU - Klesges, Lisa M.

AU - King, Allison

AU - Wun, Ted

AU - Shah, Nirmish

AU - Gibson, Robert W.

AU - Hankins, Jane S.

N1 - Funding Information: The SCD Implementation Consortium has been supported by US Federal Government cooperative agreements HL133948, HL133964, HL133990, HL133996, HL133994, HL133997, HL134004, HL134007, and HL134042 from the National Heart Lung and Blood Institute and the National Institute on Minority Health and Health Disparities (Bethesda, MD). Funding Information: JSH receives research funding support from Global Blood Therapeutics and Novartis and is a consultant for Bluebird Bio and National Committee for Quality Assurance; LLH is a consultant for Emmi Corp, Hilton Publishing, Pfizer, Global Blood Therapeutics, and AstraZeneca; JG receives research funding support from Pfizer; AK owns stock in Magenta Therapeutics; TW receives research funding support from Pfizer; NS receives speaker honoraria and research funding support from Novartis. All other authors declare no competing financial interests.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85055029225&partnerID=8YFLogxK

U2 - 10.1002/ajh.25282

DO - 10.1002/ajh.25282

M3 - Letter

C2 - 30203558

AN - SCOPUS:85055029225

SN - 0361-8609

VL - 93

SP - E391-E395

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 12

ER -